tiprankstipranks
Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
Germany Market
9IP1
Rocket Pharmaceuticals
RESEARCH TOOLSreports

Rocket Pharmaceuticals (9IP1) Income Statement

3 Followers

Rocket Pharmaceuticals Income Statement

Last quarter (Q4 2025), Rocket Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Rocket Pharmaceuticals's net income was $-42.54M. See Rocket Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -11.03M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 217.49M$ 273.20M$ 259.66M$ 224.34M$ 167.25M
Depreciation and Amortization
$ 11.03M$ 9.38M$ 7.10M$ 6.27M$ 5.37M
EBITDA
$ -210.21M$ -247.49M$ -236.62M$ -213.69M$ -157.81M
Operating Income
$ -228.52M$ -273.20M$ -259.66M$ -224.34M$ -167.25M
Other Income/Expenses
$ 5.39M$ 14.46M$ 14.06M$ 2.48M$ -1.82M
Pretax Income
$ -223.12M$ -258.75M$ -245.59M$ -221.86M$ -169.07M
Net Income
$ -223.12M$ -258.75M$ -245.59M$ -221.86M$ -169.07M
Per Share Metrics
Basic EPS
$ -2.01$ -2.73$ -2.92$ -3.26$ -2.68
Diluted EPS
$ -2.01$ -2.73$ -2.92$ -3.26$ -2.68
Weighted Average Shares Outstanding
 111.12M 94.81M 84.01M 68.15M 63.24M
Weighted Average Shares Outstanding (Diluted)
 111.12M 94.81M 84.01M 68.15M 63.24M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History